Trials / Recruiting
RecruitingNCT06879743
Effect of Suboccipital Release in Patients With Fibromyalgia Syndrome
Effect of Suboccipital Release on Neck Pain and Quality of Life in Patients With Fibromyalgia Syndrome
- Status
- Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 40 (estimated)
- Sponsor
- Cairo University · Academic / Other
- Sex
- Female
- Age
- 20 Years – 45 Years
- Healthy volunteers
- Not accepted
Summary
This study was designed to examine the efficacy of suboccipital release in Patients With FMS and to provide preliminary evidence regarding its effects on pain and QOL by objectively measuring Cortisol level in FMS patien
Detailed description
Forty female patients with FM ( age : 20- 45 Years ) participated in the study after suing the consent form . Participants were randomly allocated assigned into 2 equal groups ( control group \[ G1 \] and study \[G2 \] ) . Group 1 received selected physical therapy programme. Group 2 recieved suboccipital release. All participants were assessed for cortisol and pain level by using visual analogues scale and neck disability scale. Also participants were assessed by pressure algometer for pain intensity. Participants were assessed for QOL by FIBROMYALGIA IMPACT QUESTIONNAIRE (FIQR) . treatment was done 3 sessions per weeks for successive 6 weeks pre and post assessment for all valuable were Done
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Suboccipital release | The ptients in this group recieve suboccipital release. The patient is positioned in a supine (lying on their back) position, allowing full relaxation of the cervical spine. The therapist places their fingertips or hands under the patient's occiput, making contact with the suboccipital muscles. Using gentle, sustained pressure, the therapist allows the weight of the head to create a release, often holding for 1-5 minutes. Subtle adjustments may be made, such as slight traction or rocking, to facilitate myofascial release and relaxation. |
Timeline
- Start date
- 2024-02-01
- Primary completion
- 2025-04-01
- Completion
- 2025-04-10
- First posted
- 2025-03-17
- Last updated
- 2025-03-17
Locations
1 site across 1 country: Egypt
Source: ClinicalTrials.gov record NCT06879743. Inclusion in this directory is not an endorsement.